Table of content for "Axicabtagene ciloleucel car+" (HCPCS Q2041)
General information on the “Q2041” code
HCPCS Code: Q2041
Long Description: Axicabtagene ciloleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
Short Description: Axicabtagene ciloleucel car+
Original information is taken from Q2041 page
Pricing indicators
Pricing Indicator Code 1: 51 – Drugs
Multiple Pricing Indicator Code A : Not applicable as HCPCS priced under one methodology
Certification and additional reference information
Coverage
Coverage: C – Carrier judgment
Type of service
Berenson-Eggers Type of Service (BETOS): O1E – Other drugs
Type Of Service 1: 1 – Medical care
Misc information
Anesthesia Base Unit Quantity: 0
Code Added Date: 20180401
Code Effective Date: 20190101
Action Code: N – No maintenance for this code